Director, CEO & President · NEUROONE MEDICAL TECHNOLOGIES Corp · NEUROONE MEDICAL TECHNOLOGIES Corp — Option to Purchase Common Stock
Side
A
Value
—
Shares
68.0K
Price
—
Executed
Aug 28, 2026
Disclosed
Aug 28, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Aug 28 executedAug 28, 2026 disclosed
NMTC · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
NEUROONE MEDICAL TECHNOLOGIES Corp — Option to Purchase Common Stock
Ticker
NMTC
Shares
68.0K
Price per share
$0
Execution date (reported)
Aug 28, 2026
Owned after transaction
68.0K shares
Days from execution to publication
0
What this establishes
Rosa David A filed this Form 4 reporting a grant or award of NMTC on Aug 28, 2026. It became public on Aug 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO & President
Rosa David Acik:0001540354
Issuer
NEUROONE MEDICAL TECHNOLOGIES Corpcik:0001500198
Revision history · 0
No field has changed since this record was first ingested.
